Welcome to the World Federation of ADHD
In August 2008, the World Federation of ADHD (Attention Deficit Hyperactivity Disorder) and allied disorders was founded in Zurich, Switzerland. Professor Andreas Warnke, Director of the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy at the University of Würzburg, Germany, was officially nominated the first president of this non-profit organisation.
ADHD is a highly heritable childhood-onset psychiatric condition, which is characterized by age-inappropriate levels of the core symptoms inattention, hyperactivity and impulsivity. The disorder affects about 5 % of the children worldwide. Recent scientific studies in ADHD reveal biological underpinnings such as multiple genetic factors, ADHD-related differences in brain structure and function, as well as changes in neurotransmitter components within the basal ganglia thalamocortical neurocircuitries.
06 November 2014
Abstracts Review – Issue of November 2014 now online:
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J, Castells X, Ehimare UP, Smith CH.
Cochrane Database Syst Rev. 2014 Sep 19;9:CD006997. [Epub ahead of print]
Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Irritability: Results From the Multimodal Treatment Study of Children With ADHD (MTA)
Lorena Fernández de la Cruz, Emily Simonoff, James J. McGough, Jeffrey M. Halperin, L. Eugene Arnold, Argyris Stringaris
Journal of the American Academy of Child & Adolescent Psychiatry - 20 October 2014 (10.1016/j.jaac.2014.10.006)
20 August 2014
New blog-article online:
EPA-0398 – Parent-training intervention among a group of parents of children with ADHD
L. Luccherino, F. Mancini, C. Mercurio
Prof. Margarete Weiss from Canada presents scientific abstracts on a regular basis. You are invited to discuss and leave your thoughts and perspectives on that topic:
Let us know what you think about it – we are looking forward to your perspectives: